Summary:
Speaking to The Tribune he said the vaccine trials were progressing very well and early results were “very encouraging”. The PGI Chandigarh had already administered the second dose of vaccine to 100 volunteers as part of the ongoing phase 3 trials in India he added. “Early phase trial results from the PGI showed strong safety outcomes in 149 participants who were administered the first dose of Covishield. In the final and third phase of the trial all participants will be inoculated with the second dose. Unlike the Pfizer vaccine that requires minus 70°C storage structures Covishield can be stored between 2 to 8°C..